Intellia Therapeutics Inc. (NTLA), a clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, has several upcoming key clinical program milestones to watch in the coming months.
CRISPR, which stands for "clustered interspaced short palindromic repeats", is a technology used to edit genes.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com